Comparison of Caffeine Metabolism by Slices, Microsomes and Hepatocyte Cultures from Adult Human Liver

References

• Aldridge A., Aranda J. V., Neims A. H. Caffeine metabolism in the newborn. Clinical Pharmacology and Therapeutics 1979; 25: 447–453
   PubMed Web of Science ®Google Scholar
• Arnaud M. J. Identification, kinetic and quantitative study of ‘2‐14C’ and ‘1‐Me‐14C’ caffeine metabolites in rat's urine by chromatographic separations. Biochemical Medicine 1976; 16: 67–76
   PubMed Web of Science ®Google Scholar
• Arnaud M. J., Welsch C. Comparison of caffeine metabolism by perfused liver and isolated microsomes. Microsomes, Drug Oxidations and Chemical Carcinogenesis, M. J. Coon, A. H. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette, P. J. O'Brien. Academic Press, New York 1980a; 813–816
   Google Scholar
• Arnaud M. J., Welsch C. Caffeine metabolism in human subjects. ASIC, 9 ème colloque, Londres 1980; 385–396
   Google Scholar
• Arnaud M. J. Products of metabolism of caffeine. Caffeine: Perspectives From Recent Research, P. B. Dews. Springer‐Verlag, Berlin 1984; 3–38
   Google Scholar
• Benford D. Intact cells as a biological model for metabolism. Drug Metabolism‐From Molecules to Man, D. Benford, J. W. Bridges, G. G. Gibson. Taylor & Francis, London 1987; 392–400
   Google Scholar
• Berthou F., Alix D., Riché C., Picart D., Dréano Y., Gouédard H. Utilisation de la caféine dans le traitement des apnées chez le prématuré. Developmental Pharmacology and Therapeutics 1982; 4: 187–196
   PubMedGoogle Scholar
• Berthou F., Ratanasavanh D., Riché C., Guillouzo A. Caffeine metabolism by human and rat hepatocytes in primary culture. Liver Cells and Drugs, A. Guillouzo. INSERM/John Libbey‐Eurotext, Paris 1988; Vol. 164: 287–292
   Google Scholar
• Berthou F., Ratanasavanh D., Alix D., Carlhant D., Riché C., Guillouzo A. Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes. Biochemical Pharmacology 1988; 37: 3691–3700
   PubMed Web of Science ®Google Scholar
• Bonati M., Garattini S. Interspecies comparison of caffeine disposition. Caffeine: Perspectives From‐Recent Research, P. B. Dews. Springer‐Verlag, Berlin 1984; 48–56
   Google Scholar
• Boobis A. R., Broodie M. J., Kahn G. C., Flechter D. R., Saunders J. H., Davies D. S. Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. British Journal of Clinical Pharmacology 1980; 9: 11–19
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Davies D. S. Human cytochromes P‐450. Xenobiotica 1984; 14: 151–185
   PubMed Web of Science ®Google Scholar
• Burke M. D., Mayer R. T. Differential effects of phenobarbitone and 3‐methylcholanthrene induction of the hepatic microsomal metabolism and cytochrome P‐450 binding of phenoxazone and a homologous series of its n‐alkyl ethers (alkoxyresorufins). Chemical Biological Interactions 1983; 45: 243–258
   PubMed Web of Science ®Google Scholar
• Campbell M., Grant D., Inaba T., Kalow W. Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic hydrocarbon‐inducible cytochrome(s) P‐450 in human liver microsomes. Drug Metabolism and Disposition 1987; 15: 237–249
   PubMed Web of Science ®Google Scholar
• Ferrero J. L., Neims A. H. Metabolism of caffeine by mouse liver microsomes. GSH or cytosol causes a shift in products from 1,3,7‐trimethylurate to a substituted diaminouracil. Life Sciences 1983; 33: 1173–1178
   PubMed Web of Science ®Google Scholar
• Gorodischer R., Yaari A., Margalith M., Warszawski D., Ben‐Zvi Z. Changes in theophylline metabolism during postnatal development in rat liver slices. Biochemical Pharmacology 1986; 35: 3077–3081
   PubMed Web of Science ®Google Scholar
• Grant D. M., Tang K. B., Kalow W. Variability in caffeine metabolism. Clinical Pharmacology and Therapeutics 1983; 33: 591–602
   PubMed Web of Science ®Google Scholar
• Grant D. M., Campbell M. E., Tang K. B., Kalow W. Biotransformation of caffeine by microsomes from human liver: kinetics and inhibitory studies. Biochemical Pharmacology 1987; 36: 1251–1260
   PubMed Web of Science ®Google Scholar
• Guguen‐Guillouzo C., Campion J. P., Brissot P., Glaise D., Launois B., Bourel M., Guillouzo A. High yield preparation of isolated adult human hepatocytes by enzymatic perfusion of the liver. Cell Biology International Reports 1982; 6: 625–628
   PubMedGoogle Scholar
• Ioannindes C., Parke D. V. The cytochrome P‐448‐A unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochemical Pharmacology 1987; 36: 4197–4207
   PubMed Web of Science ®Google Scholar
• Jung B., Graf H., Ullrich V. A new monooxygenase product from 7‐ethoxycoumarin and its relation to the O‐dealkylation reaction. Biological Chemistry Hoppe‐Seyler 1985; 255: 23–31
   Google Scholar
• Kahn G. C., Boobis A. R., Murray S., Brodie M. J., Davies D. S. Assay and characterisation of debrisoquine 4‐hydroxylase activity of microsomal fractions of human liver. British Journal of Clinical Pharmacology 1982; 13: 637–645
   PubMed Web of Science ®Google Scholar
• Kalow W. Genetic variation in the human hepatic cytochrome P‐450 system. European Journal of Clinical Pharmacology 1987; 31: 633–641
   PubMed Web of Science ®Google Scholar
• Kronbach T., Mathys D., Gut J., Catin T., Meyer U. A. High performance liquid chromatography assays for bufuralol 1‐hydroxylase, debrisoquine 4‐hydroxylase and dextromethorphan O‐demethylase in microsomes and purified cytochrome P‐450 isozymes of human liver. Analytical Biochemistry 1987; 162: 24–32
   PubMed Web of Science ®Google Scholar
• Larrey D., Annouyal G., Tissel M., Letteron P., Berson A., Labbe G., Pessayre D. Polymorphism of dextromethorphan oxidation in a French population. British Journal of Clinical Pharmacology 1987; 24: 676–679
   PubMed Web of Science ®Google Scholar
• Lelo A., Miners O., Robson R., Birkett D. J. Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clinical Pharmacology and Therapeutics 1986a; 39: 56–59
   Web of Science ®Google Scholar
• Lelo A., Miners R. A., Birkett D. J. Quantitative assessment of caffeine partial clearances in man. British Journal of Clinical Pharmacology 1986b; 22: 183–186
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. G., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Maurel P., Dalet‐Beluche I., Dalet C., Bonfils C., Boivers P., Bauret P., Michel H. Activités enzymatiques et dosage immunologique d'une forme de cytochrome P‐450 microsomale dans des biopsies hépatiques à l'aiguille. Hepatoxicity of Drugs, J. P. Fillastre. INSERM publ., Rouen 1986; 287–304
   Google Scholar
• Muir K. T., Jonkman J. H. G., Tang D. S., Kunitani M., Riegelman S. Simultaneous determination of theophylline and its major metabolites in urine by reversed‐phase ion‐pair h.p.l.c. Journal of Chromatography 1980; 221: 85–95
   PubMed Web of Science ®Google Scholar
• Müller‐Enoch D., Greischel A. A direct h.p.l.c.‐method for measuring cytochrome P‐450 activities with scoparone as substrate. Liver Cells and Drugs, A. Guillouzo. INSERM/John Libbey Eurotext, Paris 1988; Vol. 164: 85–88
   Google Scholar
• Omura T., Sato E. Carbon monooxide binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2379
   PubMed Web of Science ®Google Scholar
• Prough R. A., Burke M. D., Mayer R. T. Direct fluorimetric methods for measuring mixed‐function oxidases activities. Methods in Enzymology, S. Fleischer, L. Packer. Academic Press, New York 1978; Vol. 52: 372–377
   Google Scholar
• Renner E., Wietholtz H., Huguenin P., Arnaud M. J., Preisig R. Caffeine: a model compound for measuring liver function. Hepatology 1984; 4: 38–48
   PubMed Web of Science ®Google Scholar
• Schmid B., Bircher M. D., Preisig R., Küpfer A. Polymorphic dextromethorphan metabolism: co‐segregation of oxidative O‐demethylation with debrisoquine hydroxylation. Clinical Pharmacology and Therapeutics 1985; 38: 618–624
   PubMed Web of Science ®Google Scholar
• Scott N. R., Chakraborty J., Marks V. Determination of the urinary metabolites of caffeine and theophylline by h.p.l.c. A comparative study of direct injection and an ion‐pair extraction procedure. Journal of Chromatography 1986; 375: 321–329
   PubMed Web of Science ®Google Scholar
• Tang‐Liu D. D., Riegelman S. An automated h.p.l.c. assay for simultaneous quantitation of methylated xanthines and uric acids in urine. Journal of Chromatography 1982; 20: 155–159
   Google Scholar
• Tang‐Liu D. D., Williams R. L., Riegelman S. Disposition of caffeine and its metabolites in man. Journal of Pharmacology and Experimental Therapeutics 1983; 224: 180–185
   PubMed Web of Science ®Google Scholar
• Tauc M., Hermann M., Dansette P. M., Vandecastelle J. P. Enzymatic characterization of the polynuclear aromatic hydrocarbons activating rat‐liver preparations used in the mutagenicity test of Ames. Mutation Research 1984; 125: 123–133
   PubMed Web of Science ®Google Scholar
• Warszawski D., Ben‐Zvi Z., Gorodischer R. Caffeine metabolism in liver slices during postnatal development in the rat. Biochemical Pharmacology 1981; 30: 3145–3150
   PubMed Web of Science ®Google Scholar
• Wietholtz H., Voegelin M., Arnaud M. J., Bircher J., Preisig R. Assessment of the cytochrome P‐448 dependent liver enzyme system by a caffeine breath test. European Journal of Clinical Pharmacology 1981; 21: 53–59
   PubMed Web of Science ®Google Scholar
• Williams F. M., Mutch E., Woodhouse K. W., Lambert D., Rawlins M. D. Ethoxyresorufin deethylation by human liver microsomes. British Journal of Clinical Pharmacology 1986; 22: 263–268
   PubMed Web of Science ®Google Scholar